A Clarion Call and the Crucial Next Steps, India’s Multifront War Against Antimicrobial Resistance

A Clarion Call and the Crucial Next Steps, India’s Multifront War Against Antimicrobial Resistance

Introduction: The Prime Minister’s Podium and a Public Health Awakening

On December 28, 2025, in his 129th Mann Ki Baat address, Prime Minister Narendra Modi accomplished what years of policy documents and expert warnings had struggled to achieve: he placed the complex, creeping crisis of Antimicrobial Resistance (AMR) squarely into the mainstream consciousness of a nation of 1.4 billion. By terming AMR a “matter of concern for us,” citing stark data from the Indian Council of Medical Research (ICMR) on failing antibiotics, and pinpointing the “thoughtless and indiscriminate use of antibiotics by people” as the core problem, PM Modi performed a vital act of public health translation. He distilled a scientific emergency into a clear, actionable civic directive: “Avoid taking medicines by yourself, particularly antibiotics.” This moment is undeniably pivotal. For the first time, the battle against AMR has been framed not just as a medical or bureaucratic challenge, but as a national mission requiring every citizen’s vigilance. However, as Ramya Kannan’s incisive analysis underscores, while this high-decibel awareness signal is a necessary and powerful catalyst, it is merely the opening chord. To truly “sharpen India’s AMR battle,” this signal must be fine-tuned into a sustained, data-driven, and multi-sectoral symphony of action across the human, animal, and environmental domains—the essence of the “One Health” approach.

The Looming Shadow: Understanding the AMR Catastrophe

Antimicrobial Resistance occurs when bacteria, viruses, fungi, and parasites evolve to withstand the medicines designed to destroy them. This renders standard treatments ineffective, infections persistent, and minor injuries or routine surgeries potentially deadly. For India, the stakes are catastrophically high. The country bears a disproportionate burden of infectious diseases, has some of the world’s highest rates of antibiotic consumption, and faces unique socio-economic drivers that fuel misuse.

The drivers form a perfect storm:

1. Human Health Misuse: This includes patient demand for antibiotics for viral infections like colds and flu, often pressured by the desire for a quick “fix.” It encompasses empiric prescription by doctors—prescribing broad-spectrum antibiotics without confirmatory tests due to time constraints, diagnostic uncertainty, or patient pressure. Most critically, it is enabled by the rampant over-the-counter (OTC) sale of antibiotics without a prescription, a violation of law that is nonetheless the norm in countless pharmacies.

2. Agricultural and Veterinary Overuse: In livestock, poultry, and aquaculture, antibiotics are used liberally not just for treating sick animals but, more problematically, as growth promoters and for routine disease prevention in crowded, unhygienic conditions. While the use of colistin, a last-resort antibiotic, as a growth promoter was banned in 2019, enforcement is weak, and other critical antibiotics remain in use.

3. Environmental Contamination: Pharmaceutical manufacturing effluent, along with unmetabolized antibiotics excreted by humans and animals, pollutes rivers, lakes, and soil. This creates environmental reservoirs where bacteria are constantly exposed to low levels of drugs, accelerating the development and spread of resistant genes.

PM Modi’s address brilliantly and correctly targeted the most visible node in this web: the self-medicating citizen. By speaking directly to the public, he aims to erode the deep-seated cultural belief that “popping a pill will solve everything.” This top-down, authoritative messaging has the unique power to shift social norms and create a bottom-up demand for responsible antibiotic use, potentially curbing one of the most significant drivers of resistance.

The Data Desert: Why Surveillance is the Strategic Linchpin

Yet, awareness without accurate intelligence is a campaign fought in the dark. This is where Kannan’s article strikes at the heart of India’s strategic vulnerability. The nation’s surveillance apparatus for AMR, the National AMR Surveillance Network (NARS-Net), is critically underpowered and unrepresentative. Established in 2013 and feeding into the WHO’s GLASS system, NARS-Net’s approximately 60 sentinel sites are overwhelmingly located in urban, tertiary-care government medical colleges.

This geographical and institutional bias creates a dangerous illusion. The resistance patterns seen in a premier Delhi or Chennai hospital represent the “end of the pipeline”—complex cases referred from elsewhere, often after multiple rounds of failed antibiotics. They do not reflect the ground reality in the places where most Indians first seek care: the private clinic in a small town, the district hospital, or the primary health centre in a village. As Dr. Abdul Ghafur argues, excluding these primary and secondary care centres, which handle the vast majority of community-acquired infections, means the national data is neither “balanced” nor “representative.” We are, in effect, mapping the apex of the iceberg while ignoring its submerged, vastly larger base.

The consequences are dire:

• Misguided Policy: National treatment guidelines and essential medicine lists are formulated based on skewed data, potentially recommending drugs that are already ineffective at the community level.

• Blind Spots for Emerging Threats: New resistance mechanisms can emerge and spread in rural or peri-urban communities long before they are detected by the urban-centric surveillance net.

• Ineffective Interventions: Public health campaigns and antibiotic stewardship programs cannot be targeted efficiently if we do not know the precise geographical and demographic hotspots of specific resistance patterns.

Therefore, the “urgent need,” as the article states, is a quantum leap in surveillance. NARS-Net must expand tenfold, incorporating:

• A Tiered Network: Integrating sentinel sites in district hospitals (secondary care), community health centres (primary care), and private hospitals of all sizes.

• Private Sector Integration: This is non-negotiable. Over 70% of healthcare in India is delivered privately. A surveillance system that excludes this sector is functionally blind. This requires building trust, providing technical and financial support, and creating streamlined data-sharing protocols.

• One Health Surveillance: Parallel systems must be established to monitor antibiotic use and resistance in veterinary hospitals, poultry farms, dairy cooperatives, and aquaculture units. Environmental surveillance of water bodies near pharmaceutical clusters, hospitals, and agricultural run-off must become routine.

The “One Health” Imperative: Connecting the Dots

The article correctly identifies AMR as a “hydra-headed beast” that can only be tackled through a “One Health” approach. This philosophy recognizes that the health of humans, domestic animals, wildlife, and ecosystems are inextricably linked. Antibiotic resistance genes do not respect biological or geographical boundaries; they flow freely.

A practical One Health strategy against AMR involves:

1. Integrated Governance: Breaking down the silos between the Ministry of Health & Family Welfare, the Ministry of Fisheries, Animal Husbandry & Dairying, the Ministry of Environment, Forest and Climate Change, and the Ministry of Chemicals and Fertilizers. A cabinet-level, empowered task force with a unified AMR budget is essential.

2. Regulating the Animal Sector: Moving beyond the colistin ban to a phased withdrawal of all antibiotic growth promoters, coupled with massive investments in alternatives (probiotics, vaccines, improved farm hygiene) and strict enforcement of veterinary prescription laws.

3. Controlling Pharmaceutical Pollution: Strengthening and enforcing environmental regulations for drug manufacturing units to mandate zero-liquid discharge and proper treatment of antibiotic-laced effluent.

4. Cross-Sectoral Stewardship: Promoting antibiotic stewardship not just in human hospitals but also in veterinary practices and among farmers.

From Awareness to Accountability: The Enforcement Gap

PM Modi’s speech masterfully addresses the first objective of the WHO’s Global Action Plan: raising awareness. However, the other four objectives—strengthening surveillance, reducing infection rates, optimizing antimicrobial use, and ensuring sustainable investment—remain hamstrung by a massive enforcement gap.

• Enforcing Pharmacy Regulations: The H1 rule that mandates a prescription for the sale of antibiotics is famously flouted. This requires a multi-pronged crackdown: digitizing prescriptions to create an audit trail, conducting sting operations on pharmacies, imposing severe, non-bailable penalties for violations, and rewarding compliant chemists.

• Mandating Stewardship in Healthcare: Antibiotic Stewardship Programs (ASPs)—systematic efforts to improve antibiotic use—must move from being a niche practice in elite hospitals to a mandatory accreditation requirement for all hospitals, nursing homes, and large clinics. This requires training a cadre of infectious disease specialists, clinical pharmacists, and microbiologists.

• Infection Prevention and Control (IPC): The most effective way to reduce antibiotic use is to prevent infections in the first place. Basic IPC—hand hygiene, sterile techniques, clean water, and proper sanitation—must be rigorously implemented and audited in every healthcare facility, from the largest corporate hospital to the smallest rural clinic.

Conclusion: Fine-Tuning the Signal into a National Mission

Prime Minister Narendra Modi’s Mann Ki Baat address on AMR is a watershed moment for public health communication in India. It has the potential to initiate a societal movement, changing the “pop-a-pill” culture that fuels this silent pandemic. However, to convert this potential into tangible progress, the powerful signal from the podium must be systematically fine-tuned and amplified across the entire governance spectrum.

This requires a war-footing transition from rhetoric to resources, from awareness to accountability, and from fragmented efforts to a fused “One Health” command. It demands that the political will so vividly demonstrated in the broadcast be translated into a significant budgetary commitment for surveillance expansion, IPC infrastructure, and stewardship programs. It necessitates holding not just citizens, but also pharmacists, doctors, veterinarians, farmers, and pharmaceutical manufacturers accountable for their role in the AMR chain.

The battle against AMR is a long war of attrition against an invisible, adaptable enemy. PM Modi has, with one speech, mobilized the nation’s attention—the equivalent of declaring war. Now, the hard work of building the intelligence network (surveillance), securing the supply lines (rational use), protecting the home front (infection prevention), and fighting on all fronts (One Health) begins. The time for that concerted, unglamorous, and vital work is now. The future of modern medicine in India depends on it.

Q&A Section

Q1: Why is Prime Minister Modi’s Mann Ki Baat address on AMR considered more impactful than previous policy measures like the National Action Plan?
A1: Previous measures like the 2017 National Action Plan on AMR were crucial for creating a policy framework but largely remained within bureaucratic, medical, and academic circles. PM Modi’s address leveraged his unparalleled mass communication platform to speak directly to the public. He translated complex scientific jargon into a simple, powerful message about personal responsibility (“Avoid taking medicines by yourself”). This top-down, authoritative appeal from the nation’s most influential figure has the unique potential to shift societal behavior and cultural norms on a massive scale, creating public pressure for change that policies alone cannot generate. It mainstreams the issue, making it a topic of household conversation.

Q2: What is the critical flaw in India’s current AMR surveillance system (NARS-Net), and what are the real-world consequences of this flaw?
A2: The critical flaw is its severe urban and tertiary-care bias. NARS-Net’s sentinel sites are predominantly in major government medical colleges in cities. This fails to capture resistance patterns where most infections are first diagnosed and treated: in private clinics, district hospitals, and primary health centres across semi-urban and rural India. The consequences are severe:

• Skewed Data: The national picture is unrepresentative, likely underestimating the true community prevalence of resistance.

• Misguided Treatment: National guidelines based on this data may recommend antibiotics that are already ineffective at the community level.

• Blind to Emergent Threats: New resistant strains can spread undetected in areas outside the surveillance net, leading to delayed public health responses.

Q3: What does a genuine “One Health” approach to combating AMR in India entail?
A3: A genuine “One Health” approach recognizes that human, animal, and environmental health are interconnected. To combat AMR, it entails coordinated action across all three sectors:

• Human Health: Curbing misuse in hospitals and communities via stewardship and enforcing prescription laws.

• Animal Health: Phasing out antibiotic use as growth promoters in livestock and aquaculture, promoting alternatives, and ensuring veterinary antibiotics are used only therapeutically under supervision.

• Environmental Health: Strictly regulating the disposal of antibiotic-laced waste from pharmaceutical factories, hospitals, and farms to prevent the creation of environmental reservoirs of resistance.
  This requires breaking down ministerial silos and creating a unified, cross-sectoral governance structure with a shared AMR strategy and budget.

Q4: Beyond public awareness, where are the biggest enforcement gaps in India’s AMR fight?
A4: The biggest enforcement gaps are systemic:

• Pharmacy Regulation: The ban on over-the-counter antibiotic sales without a prescription (Schedule H1) is widely ignored due to lax enforcement, lack of digital tracking, and minimal penalties for violators.

• Agricultural Use: Bans on growth promoters like colistin are poorly enforced at the farm level. There is little monitoring of antibiotic use in the massive and unorganized livestock and poultry sectors.

• Hospital Stewardship: Antibiotic Stewardship Programs (ASPs) are not mandatory for hospital accreditation. Most small and private facilities have no ASPs, leading to unrestricted, irrational prescribing by doctors.

• Industrial Pollution: Standards for treating antibiotic-laden effluent from pharmaceutical plants are weak and poorly monitored, allowing resistant genes to enter waterways.

Q5: How can the momentum from the Prime Minister’s speech be concretely translated into on-ground progress?
A5: Concrete translation requires immediate, coordinated action:

1. Surge in Surveillance Funding: Allocate substantial funds to rapidly scale up NARS-Net to include thousands of sentinel sites in private and public primary/secondary care and establish animal/environmental surveillance.

2. Launch a National “Antibiotic Smart” Campaign: A sustained multi-media campaign in local languages, reinforcing the PM’s message and educating on the One Health links (e.g., how farm use affects human health).

3. Strengthen Enforcement: Conduct a nationwide drive to enforce prescription-only sales using technology (e-parcha) and impose hefty, non-bailable fines on violating pharmacies. Simultaneously, ramp up inspections of veterinary drug sellers and feed mills.

4. Make Stewardship Mandatory: Amend hospital accreditation norms to require functional ASPs in all hospitals above a certain bed capacity, with government support for training.

5. Create a High-Powered Task Force: Establish a cross-ministerial, time-bound mission with direct reporting to the PMO to coordinate and drive all these actions, ensuring accountability and breaking bureaucratic logjams.